Most people come to me having already tried the obvious things. A couple of antidepressants. Maybe therapy. Often both, for years. And they arrive with a reasonable question: if one treatment didn't fix this, why would another?

It's a fair worry. But it rests on an assumption I'd like to gently challenge — that depression treatment is a single-lane road, where you try one thing, then the next, then the next, until something works or you run out of options. In practice, some of the most stubborn depressions respond best not to a treatment, but to two treatments doing different jobs at the same time.Two of those tools are TMS and ketamine. On their own, each helps a meaningful number of people. Used thoughtfully together, there's growing reason to think they can do more than either does alone. I want to walk you through why that might be — and, just as importantly, where the honest limits of that idea are.

A quick reminder of what each one does

TMS (transcranial magnetic stimulation) uses focused magnetic pulses to gently stimulate the parts of the brain involved in mood regulation. It's non-invasive, you're awake, you drive yourself home, and there's no anaesthesia. Its main strength is that it builds a durable change — but it takes time. A standard course runs over several weeks, and most people feel the shift gradually rather than overnight.

Ketamine, given in a supervised medical setting, works through an entirely different mechanism. Its main strength is the mirror image of TMS: it can lift mood quickly — sometimes within days — which is why it's taken so seriously for severe, treatment-resistant depression and for people in acute distress. Its limitation is also the mirror image: that early lift often needs maintenance to hold.

So you have one treatment that is fast but tends to fade, and one that is slow but tends to last. You can probably already see where this is going.

The rationale for combining them

Put simply: ketamine may open a door, and TMS may help you walk through it while it's open.

Here's the idea in plain terms. Part of what makes ketamine interesting isn't just the mood lift — it's that it appears to briefly increase the brain's plasticity, its capacity to form and reshape connections. For a short window of days, the brain may be more changeable than usual. Some clinicians reason that delivering targeted stimulation like TMS during that window could help the brain make better use of it — as if you're doing the rewiring exercises while the wiring is unusually flexible.

There's a practical version of the argument too, quite apart from any biology. Ketamine can carry someone through the dangerous, exhausting first couple of weeks while a TMS course — which needs time to work — gets going underneath. Fast relief buys time; durable relief holds the ground. Different jobs, complementary timing.

What the evidence actually shows (and doesn't)

I want to be straight with you here, because this is exactly the kind of area where hype outruns proof.

A 2024 systematic review looked at the studies combining TMS and ketamine for treatment-resistant depression. The signal was encouraging: across the studies, the combination produced substantial and sustained improvement in depressive symptoms, and appeared to do better than either treatment used alone. Side effects were generally mild and short-lived, with no severe adverse events reported in most of the work reviewed.

That's genuinely promising. But — and this matters — that review was built mostly on small studies, case reports and pilot trials, with different designs and no large randomized controlled trials to anchor it. In medicine, that combination of "looks good" and "not yet proven at scale" should make you interested, not certain. We don't yet have the big, definitive trials that would let anyone honestly call this a standard protocol. The sequencing, the timing, the ideal doses — these are still being worked out.

So the fair summary is this: combining TMS and ketamine is a reasonable, evidence-informed option for the right person, not a guaranteed upgrade for everyone. Anyone who promises you the latter is selling, not advising.

Who it might suit — and who it probably doesn't

In my practice, the people I'd actually consider this for tend to share a few features. They have genuinely treatment-resistant depression — several adequate treatments tried without lasting success. They may need both speed and durability: perhaps the depression is severe enough that waiting weeks for TMS alone feels risky, but we also want a result that outlasts a course of ketamine. And they're able to commit to the schedule and the supervision that both treatments require.

It's less likely to be the first thing I reach for if someone hasn't yet had a fair trial of simpler, well-established approaches, or if their situation is better served by one modality done properly. More is not automatically better in psychiatry. Two treatments mean two side-effect profiles, more appointments, and more cost — none of which is worth taking on unless there's a real reason to expect the combination to earn its keep.

That's a decision to make carefully, with a psychiatrist who knows both treatments well and, crucially, knows you — your history, your risks, your goals.

What doing it responsibly looks like

If a combined approach does make sense, a few things should be non-negotiable. Both treatments happen under proper medical supervision — ketamine especially is not something to improvise or source informally. There's a clear plan for sequencing and for what "success" looks like, agreed in advance. We measure as we go, using structured symptom tracking rather than vibes, and we're willing to change course if the data says to. And you understand the honest state of the evidence before you start, not after.

None of that is meant to scare you off. It's meant to describe what careful, unhurried care looks like — the opposite of a clinic that offers everything to everyone.

The bigger point

The reason I find this area hopeful isn't the specific pairing of TMS and ketamine. It's the shift in thinking behind it. Treatment-resistant depression has, for too long, been treated as a dead end — you failed the medications, so that's that. The truth is that "treatment-resistant" usually means "hasn't yet found the right combination," not "untreatable." Tools that work through different mechanisms, timed to complement each other, are one of the more promising ways out of that dead end.

If you've tried the usual routes and feel stuck, that stuckness is information, not a verdict. It's worth sitting down with someone who can look at the whole toolkit — TMS, ketamine, the combination, or something else entirely — and think clearly about what fits your situation.

Dr. Anuranjan Bist is a US board-certified psychiatrist and the founder of Mind Brain Institute, with clinics in New Delhi and USA. This article is general information, not medical advice; treatment decisions — especially any involving ketamine or combined treatments — should be made with a qualified psychiatrist who can assess your individual situation. If you are in crisis or having thoughts of harming yourself, please contact your local emergency services or a mental health helpline right away.